The results from a recent phase 3 trial indicate that mepolizumab significantly reduces moderate and severe exacerbations in patients with eosinophilic chronic obstructive pulmonary disease.
The FDA approved Zongertinib for adults with unresectable or metastatic non-squamous NSCLC with HER2 (ERBB2) TKD activating mutations following prior systemic therapy.
Using national survey data and interpretable machine learning, researchers identified specific per- and polyfluoroalkyl substances that either increase or reduce the risk of chronic obstructive pulmonary...
A recent study suggests that an 8-week online mindfulness program may help alleviate dyspnea in patients with interstitial lung disease, a condition often resistant to conventional treatments.
A recent study explored the impact of high-flow nasal cannula therapy on exercise tolerance in patients with interstitial lung disease, showing benefits with oxygen supplementation in improving endurance...
The FDA has proposed new draft guidance to improve the accuracy of pulse oximeters across all skin tones, addressing long-standing concerns about potential disparities in performance.
The FDA is seeking a cap on nicotine levels in cigarettes and certain tobacco products at minimally or nonaddictive levels. This initiative, if finalized, would be what the FDA calls a “significant step”...
The CDC has updated its guidelines for COVID-19 and pneumococcal vaccines, aiming to boost protection for high-risk populations against severe disease year-round.
